Adolescent polycystic ovary syndrome according to the international evidence-based guideline

被引:135
|
作者
Pena, Alexia S. [1 ,2 ]
Witchel, Selma F. [3 ]
Hoeger, Kathleen M. [4 ]
Oberfield, Sharon E. [5 ]
Vogiatzi, Maria G. [6 ]
Misso, Marie [6 ,7 ,8 ]
Garad, Rhonda [7 ,8 ]
Dabadghao, Preeti [9 ]
Teede, Helena [7 ,8 ]
机构
[1] Univ Adelaide, Discipline Paediat, Robinson Res Inst, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Womens & Childrens Hosp, Endocrine Dept, 72 King William Rd, Adelaide, SA 5006, Australia
[3] Univ Pittsburgh, Dept Pediat, Div Pediat Endocrinol, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA
[4] Univ Rochester, Med Ctr, Dept OBGYN, Rochester, NY 14642 USA
[5] Columbia Univ, Irving Med Ctr, Div Pediat Endocrinol, New York, NY USA
[6] Univ Philadelphia, Perelman Sch Med, Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA USA
[7] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia
[8] Monash Hlth, Melbourne, Vic, Australia
[9] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India
基金
澳大利亚国家健康与医学研究理事会;
关键词
Adolescents; Girls; Polycystic ovary syndrome; Evidence-based; Diagnosis; Treatment; ANTI-MULLERIAN HORMONE; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE MODIFICATION; LOW-DOSE FINASTERIDE; BODY-MASS INDEX; QUALITY-OF-LIFE; MENSTRUAL-CYCLE; ORAL-CONTRACEPTIVES; ANXIETY SYMPTOMS; PREDICTIVE-VALUE;
D O I
10.1186/s12916-020-01516-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diagnosing polycystic ovary syndrome (PCOS) during adolescence is challenging because features of normal pubertal development overlap with adult diagnostic criteria. The international evidence-based PCOS Guideline aimed to promote accurate and timely diagnosis, to optimise consistent care, and to improve health outcomes for adolescents and women with PCOS. Methods International healthcare professionals, evidence synthesis teams and consumers informed the priorities, reviewed published data and synthesised the recommendations for the Guideline. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied to appraise the evidence quality and the feasibility, acceptability, cost, implementation and strength of the recommendations. Results This paper focuses on the specific adolescent PCOS Guideline recommendations. Specific criteria to improve diagnostic accuracy and avoid over diagnosis include: (1) irregular menstrual cycles defined according to years post-menarche; > 90 days for any one cycle (> 1 year post-menarche), cycles< 21 or > 45 days (> 1 to < 3 years post-menarche); cycles < 21 or > 35 days (> 3 years post-menarche) and primary amenorrhea by age 15 or > 3 years post-thelarche. Irregular menstrual cycles (< 1 year post-menarche) represent normal pubertal transition. (2) Hyperandrogenism defined as hirsutism, severe acne and/or biochemical hyperandrogenaemia confirmed using validated high-quality assays. (3) Pelvic ultrasound not recommended for diagnosis of PCOS within 8 years post menarche. (4) Anti-Mullerian hormone levels not recommended for PCOS diagnosis; and (5) exclusion of other disorders that mimic PCOS. For adolescents who have features of PCOS but do not meet diagnostic criteria an 'at risk' label can be considered with appropriate symptomatic treatment and regular re-evaluations. Menstrual cycle re-evaluation can occur over 3 years post menarche and where only menstrual irregularity or hyperandrogenism are present initially, evaluation with ultrasound can occur after 8 years post menarche. Screening for anxiety and depression is required and assessment of eating disorders warrants consideration. Available data endorse the benefits of healthy lifestyle interventions to prevent excess weight gain and should be recommended. For symptom management, the combined oral contraceptive pill and/or metformin may be beneficial. Conclusions Extensive international engagement accompanied by rigorous processes honed both diagnostic criteria and treatment recommendations for PCOS during adolescence.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Adolescent polycystic ovary syndrome according to the international evidence-based guideline
    Alexia S. Peña
    Selma F. Witchel
    Kathleen M. Hoeger
    Sharon E. Oberfield
    Maria G. Vogiatzi
    Marie Misso
    Rhonda Garad
    Preeti Dabadghao
    Helena Teede
    [J]. BMC Medicine, 18
  • [2] Diagnosis of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS
    Pena, Alexia
    Hoeger, Kathy
    Oberfield, Sharon
    Wiitchel, Selma
    Vogiatzi, Maria
    Misso, Marie
    Teede, Helena
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 551 - 551
  • [3] Diagnosis and Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS
    Pena, A.
    Hoeger, K.
    Oberfield, S.
    Witchel, S.
    Vogiatzi, M.
    Misso, M.
    Teede, H.
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2018, 58 : 4 - 5
  • [4] Pharmacological Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS
    Pena, Alexia
    Witchel, Selma
    Hoeger, Kathy
    Oberfield, Sharon
    Vogiatzi, Maria
    Misso, Marie
    Teede, Helena
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 99 - 100
  • [5] Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
    Teede, Helena J.
    Misso, Marie L.
    Costello, Michael F.
    Dokras, Anuja
    Laven, Joop
    Moran, Lisa
    Piltonen, Terhi
    Norman, Robert J.
    [J]. HUMAN REPRODUCTION, 2018, 33 (09) : 1602 - 1618
  • [6] Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
    Teede, Helena J.
    Misso, Marie L.
    Costello, Michael F.
    Dokras, Anuja
    Laven, Joop
    Moran, Lisa
    Piltonen, Terhi
    Norman, Robert. J.
    [J]. FERTILITY AND STERILITY, 2018, 110 (03) : 364 - 379
  • [7] Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
    Teede, Helena J.
    Misso, Marie L.
    Costello, Michael F.
    Dokras, Anuja
    Laven, Joop
    Moran, Lisa
    Piltonen, Terhi
    Norman, Robert J.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 89 (03) : 251 - 268
  • [8] Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
    Teede, Helena J.
    Tay, Chau Thien
    Laven, Joop
    Dokras, Anuja
    Moran, Lisa J.
    Piltonen, Terhi T.
    Costello, Michael F.
    Boivin, Jacky
    Redman, Leanne M.
    Boyle, Jacqueline A.
    Norman, Robert. J.
    Mousa, Aya
    Joham, Anju E.
    [J]. FERTILITY AND STERILITY, 2023, 120 (04) : 767 - 793
  • [9] Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
    Teede, Helena J.
    Chau Thien Tay
    Laven, Joop
    Dokras, Anuja
    Moran, Lisa J.
    Piltonen, Terhi T.
    Costello, Michael F.
    Boivin, Jacky
    Redman, Leanne M.
    Boyle, Jacqueline A.
    Norman, Robert J.
    Mousa, Aya
    Joham, Anju E.
    [J]. HUMAN REPRODUCTION, 2023, 38 (09) : 1655 - 1679
  • [10] Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
    Teede, Helena J.
    Tay, Chau Thien
    Laven, Joop J. E.
    Dokras, Anuja
    Moran, Lisa J.
    Piltonen, Terhi T.
    Costello, Michael F.
    Boivin, Jacky
    Redman, Leanne M.
    Boyle, Jacqueline A.
    Norman, Robert J.
    Mousa, Aya
    Joham, Anju E.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2023, 189 (02) : G43 - G64